Amrubicin therapy improves patients with refractory small-cell lung cancer: A single-arm confirmatory Chinese clinical study
Our objective was to VEGAN FERMENTED PROTEIN UNFLAVOURED evaluate an open-label, multicenter, single-arm study to appraise whether amrubicin therapy improves patients with refractory small-cell lung cancer in Chinese clinical study.Patients (n=95) with refractory small-cell lung cancer received 3 consecutive days amrubicin therapy for 21 days.Overa